☆ 4.6 Letter

Characterization of Hyperprogression After Immunotherapy in a Lung Adenocarcinoma Patient With Strong Expression of Programmed Death Ligand 1

JOURNAL OF THORACIC ONCOLOGY (2020)

Get Full Text
Add to Collection

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 15, Issue 1, Pages E4-E8

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2019.08.007

Keywords

-

Categories

Oncology Respiratory System

Funding

  1. National Key Sci-Tech Special Project of China [2018ZX10302207]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.